James E. Lang

619 total citations
12 papers, 497 citations indexed

About

James E. Lang is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, James E. Lang has authored 12 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in James E. Lang's work include Lipoproteins and Cardiovascular Health (4 papers), Estrogen and related hormone effects (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). James E. Lang is often cited by papers focused on Lipoproteins and Cardiovascular Health (4 papers), Estrogen and related hormone effects (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). James E. Lang collaborates with scholars based in United States. James E. Lang's co-authors include Charles J. Glueck, Trent Tracy, Luann Sieve-Smith, Robert N. Fontaine, Ying Wang, Peter J. Shaw, James Speirs, Ping Wang, Patricia Streicher and M.T.R. Subbiah and has published in prestigious journals such as Journal of neurosurgery, The American Journal of Cardiology and Clinica Chimica Acta.

In The Last Decade

James E. Lang

12 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James E. Lang United States 11 167 166 129 89 61 12 497
Henk Bilo Netherlands 8 132 0.8× 118 0.7× 122 0.9× 97 1.1× 66 1.1× 13 577
F. Loehrer Switzerland 8 141 0.8× 249 1.5× 317 2.5× 131 1.5× 46 0.8× 8 563
Martin Egfjord Denmark 14 110 0.7× 97 0.6× 81 0.6× 130 1.5× 57 0.9× 53 691
Yuri Moriyama Japan 13 241 1.4× 415 2.5× 230 1.8× 121 1.4× 75 1.2× 14 771
Yutaka Kiyohara Japan 13 111 0.7× 131 0.8× 55 0.4× 67 0.8× 41 0.7× 16 528
Lena Norlund Sweden 10 55 0.3× 197 1.2× 116 0.9× 63 0.7× 66 1.1× 23 620
E. G. Wilmshurst Australia 14 405 2.4× 197 1.2× 95 0.7× 94 1.1× 105 1.7× 25 821
Jayshree Acharya United Kingdom 14 112 0.7× 147 0.9× 42 0.3× 114 1.3× 80 1.3× 20 511
B D Wilson United States 5 64 0.4× 116 0.7× 222 1.7× 77 0.9× 41 0.7× 11 391
Nadya Mothu France 10 55 0.3× 107 0.6× 44 0.3× 95 1.1× 41 0.7× 11 689

Countries citing papers authored by James E. Lang

Since Specialization
Citations

This map shows the geographic impact of James E. Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Lang more than expected).

Fields of papers citing papers by James E. Lang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Lang. The network helps show where James E. Lang may publish in the future.

Co-authorship network of co-authors of James E. Lang

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Lang. A scholar is included among the top collaborators of James E. Lang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Lang. James E. Lang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Glueck, Charles J., Ping Wang, Robert N. Fontaine, Luann Sieve-Smith, & James E. Lang. (2002). Estrogen replacement therapy, thrombophilia, and atherothrombosis. Metabolism. 51(6). 724–732. 10 indexed citations
2.
Glueck, Charles J., Robert N. Fontaine, Ping Wang, et al.. (2001). Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30. Metabolism. 50(7). 856–861. 145 indexed citations
3.
Glueck, Charles J., Ping Wang, Robert N. Fontaine, Luann Sieve-Smith, & James E. Lang. (2001). Interaction of estrogen replacement therapy with the thrombophilic 20210 G/A prothrombin gene mutation for atherothrombotic vascular disease: A cross-sectional study of 275 hyperlipidemic women. Metabolism. 50(3). 360–365. 14 indexed citations
4.
Glueck, Charles J., James E. Lang, Trent Tracy, Luann Sieve-Smith, & Ping Wang. (1999). Evidence that anticardiolipin antibodies are independent risk factors for atherosclerotic vascular disease. The American Journal of Cardiology. 83(10). 1490–1494. 28 indexed citations
5.
6.
Glueck, Charles J., James E. Lang, Trent Tracy, Luann Sieve-Smith, & Ping Wang. (1999). Contribution of fasting hyperinsulinemia to prediction of atherosclerotic cardiovascular disease status in 293 hyperlipidemic patients. Metabolism. 48(11). 1437–1444. 15 indexed citations
7.
Lang, James E., Ping Wang, & Charles J. Glueck. (1996). Myopathy associated with lipid lowering therapy in patients with previously undiagnosed or undertreated hypothyroidism. Clinica Chimica Acta. 254(1). 85–92. 13 indexed citations
8.
Glueck, Charles J., Peter J. Shaw, James E. Lang, et al.. (1995). Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients. The American Journal of Cardiology. 75(2). 132–136. 131 indexed citations
9.
Glueck, Charles J., et al.. (1992). Gemfibrozil-lovastatin therapy for primary hyperlipoproteinemias. The American Journal of Cardiology. 70(1). 1–9. 44 indexed citations
10.
Glueck, Charles J., James E. Lang, Trent Tracy, & James Speirs. (1991). The common finding of covert hypothyroidism at initial clinical evaluation for hyperlipoproteinemia. Clinica Chimica Acta. 201(1-2). 113–122. 27 indexed citations
11.
Glueck, Charles J., et al.. (1990). Lack of concordance in classification of coronary heart disease risk: high-risk HDL cholesterol less than 35 mg/dl in subjects with desirable total serum cholesterol, less than 200 mg/dl.. PubMed. 116(3). 377–85. 6 indexed citations
12.
Dumitru, Daniel & James E. Lang. (1986). Cruciate paralysis. Journal of neurosurgery. 65(1). 108–110. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henk Bilo Breakdown of academic impact, for papers by F. Loehrer Breakdown of academic impact, for papers by Martin Egfjord Breakdown of academic impact, for papers by Yuri Moriyama Breakdown of academic impact, for papers by Yutaka Kiyohara Breakdown of academic impact, for papers by Lena Norlund Breakdown of academic impact, for papers by E. G. Wilmshurst Breakdown of academic impact, for papers by Jayshree Acharya Breakdown of academic impact, for papers by B D Wilson Breakdown of academic impact, for papers by Nadya Mothu
Rankless by CCL
2026